Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blachly

Showing results (81-90 of 196) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2016
HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous LeukemiaTsung-Huei Lai, Brett Ewald, Alma Zecevic, et al.
Blood Advances|January 12, 2019
Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenibDaniel P Shenoi, Leslie A Andritsos, James S Blachly, et al.
Leukemia Research|January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemiaCaner Saygin, Nicole Grieselhuber, James Blachly, et al.
Cancer Investigation|April 21, 2017
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal CancerJohanna C Bendell, Mathew Joseph, Kirk Barnes, et al.
Haematologica|November 2, 2014
Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effectiveLeslie A Andritsos, Neil Dunavin, Gerard Lozanski, et al.
The Journal of Biological Chemistry|November 24, 1995
Lysine residues at positions 234 and 236 in yeast porin are involved in its assembly into the mitochondrial outer membraneM D Smith, M Petrak, P D Boucher, et al.
Cancers|April 26, 2025
Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid LeukemiaMatthew R Avenarius, Zachary B Abrams, Ling Guo, et al.
JCO Clinical Cancer Informatics|April 11, 2022
Challenges and Gaps in Clinical Trial Genomic Data ManagementSarah Asad, Kathryn Kananen, Kurt R Mueller, et al.
Ejhaem|November 29, 2023
Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2Kaitlin Annunzio, Michael Ozga, Ying Huang, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Pageof 20

Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2016
HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous LeukemiaTsung-Huei Lai, Brett Ewald, Alma Zecevic, et al.
Blood Advances|January 12, 2019
Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenibDaniel P Shenoi, Leslie A Andritsos, James S Blachly, et al.
Leukemia Research|January 15, 2020
Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemiaCaner Saygin, Nicole Grieselhuber, James Blachly, et al.
Cancer Investigation|April 21, 2017
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal CancerJohanna C Bendell, Mathew Joseph, Kirk Barnes, et al.
Haematologica|November 2, 2014
Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effectiveLeslie A Andritsos, Neil Dunavin, Gerard Lozanski, et al.
The Journal of Biological Chemistry|November 24, 1995
Lysine residues at positions 234 and 236 in yeast porin are involved in its assembly into the mitochondrial outer membraneM D Smith, M Petrak, P D Boucher, et al.
Cancers|April 26, 2025
Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid LeukemiaMatthew R Avenarius, Zachary B Abrams, Ling Guo, et al.
JCO Clinical Cancer Informatics|April 11, 2022
Challenges and Gaps in Clinical Trial Genomic Data ManagementSarah Asad, Kathryn Kananen, Kurt R Mueller, et al.
Ejhaem|November 29, 2023
Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2Kaitlin Annunzio, Michael Ozga, Ying Huang, et al.
Cancers|June 18, 2020
Cotargeting of XPO1 Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Acute Myeloid LeukemiaLindsey T Brinton, Steven Sher, Katie Williams, et al.
Pageof 20